You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Major Adverse Cardiovascular Events

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

Not yet recruiting
  • Obesity
  • Naltrexone-Bupropion (NB) Combination
  • Placebo
  • (no location specified)
Oct 18, 2023

Diabetes, Type 2, Major Adverse Cardiac Events Trial in Hangzhou (CGM)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Major Adverse Cardiac Events
  • CGM
  • Hangzhou, China
    the Second Affiliated Hospital Zhejiang University Schoolof Medi
Sep 23, 2023

Major Adverse Cardiovascular Events in Coronary Artery Disease

Completed
  • Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
    • Jinan, Shandong, China
      Yuguo Chen
    Sep 20, 2022

    Arteriosclerosis, Hypercholesterolaemia Trial (MK-0616, Placebo)

    Not yet recruiting
    • Arteriosclerosis
    • Hypercholesterolaemia
    • (no location specified)
    Aug 17, 2023

    Anticoagulant Drug Intervention on Postoperative MALE and MACE

    Recruiting
    • Anticoagulant Drugs
    • +2 more
    • anticoagulant or antiplatelet drugs
    • Hangzhou, None Selected, China
      First Affiliated Hospital of Zhejiang University
    May 8, 2023

    Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

    Not yet recruiting
    • Primary Prevention of Atherosclerotic Cardiovascular Disease
    • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
    • Placebo in 1.5ml
    • (no location specified)
    Feb 13, 2023

    Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)

    Not yet recruiting
    • Coronary Artery Disease Progression
    • Intensive lipid-lowering control
    • Moderate-intensity lipid-lowering control
    • (no location specified)
    Jul 13, 2022

    Coronary Artery Disease Trial in United States (Colchicine, Placebo)

    Not yet recruiting
    • Coronary Artery Disease
    • Long Beach, California
    • +4 more
    Nov 15, 2022

    Obstructive Hypertrophic Cardiomyopathy

    Completed
    • Microvascular Dysfunction
    • +2 more
      • Beijing, Beijing, China
        Fuwai Hospital, China National Center for Cardiovascular Disease
      Jan 11, 2023

      GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

      Recruiting
      • Diabetes Mellitus, Type 2
      • Myocardial Infarction
      • PCI
      • Naples, Italy
        Celestino Sardu
      Aug 31, 2023

      Major Adverse Cardiovascular Events for Naldemedine and Other

      Recruiting
      • Opioid-induced Constipation
      • Wilmington, Delaware
        Research Site
      Feb 28, 2022

      In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)

      Recruiting
      • In-stent Restenosis
      • Major Adverse Cardiovascular Events
      • Beijing, Beijing, China
        Beijing Anzhen Hospital
      Jan 16, 2023

      Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))

      Completed
      • Cardiovascular Diseases
      • cardiovascular magnetic resonance (CMR)
      • Peking, Beijing, China
        Chinese PLA General Hospital
      Apr 3, 2022

      Novel Cardiovascular Biomarkers in Patients With Kidney Disease

      Not yet recruiting
      • Haemodialysis Complication
      • Major Adverse Cardiac Events
      • Cardiac Biomarkers
      • +2 more
      • (no location specified)
      Sep 14, 2023

      MACE and PE in Elective Primary TKA & THA

      Completed
      • Cardiovascular Complication
      • +4 more
        • Larissa, Greece
          University of Thessaly
        Oct 29, 2021

        Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

        Recruiting
        • Prostate Cancer
        • Tucson, Arizona
        • +7 more
        Feb 1, 2023

        Cardiovascular Primary Prevention Strategy Trial in Murray (Coronary Artery Calcium Screening and Statin Treatment, Standard

        Recruiting
        • Cardiovascular Primary Prevention Strategy
        • Coronary Artery Calcium Screening and Statin Treatment
        • Standard Treatment
        • Murray, Utah
          Intermountain Medical Center and Intermountain Clinics
        Aug 8, 2022

        Risk Factors for Predictors of MACEs After RA-CABG

        Completed
        • Coronary Artery Disease
          • Shanghai, Shanghai, China
            Ruijin Hospital Shanghai Jiao Tong University School of Medicine
          Nov 30, 2021

          Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)

          Not yet recruiting
          • Atrial Fibrillation
          • +3 more
          • low-dose rivaroxaban
          • Standard-dose rivaroxaban
          • (no location specified)
          Oct 25, 2023

          Chest Pain, Major Adverse Cardiovascular Events Trial in Monastir (Digital plethysmography in stratifying the cardiovascular

          Completed
          • Chest Pain
          • Major Adverse Cardiovascular Events
          • Digital plethysmography in stratifying the cardiovascular risk for patients consulting for chest pain
          • Monastir, Tunisia
            University hospital of Moastir
          Dec 1, 2021

          Coronary Computed Tomography Angiography, Stable Chest Pain, Optimal Medical Therapy Trial in Beijing, Tianjin (CCTA)

          Recruiting
          • Coronary Computed Tomography Angiography
          • +6 more
          • CCTA
          • Beijing, China
          • +1 more
          Feb 21, 2022

          CT-based Myocardial Characterization (CTMyoC)

          Recruiting
          • Different Cardiomyopathy and Major Cardiovascular Adverse Events
            • Milano, Italy
              IRCCS San Raffaele
            Sep 1, 2023

            PARA-HEART Pilot Implementation

            Completed
            • Acute Coronary Syndrome
            • Chest Pain
              • Winston-Salem, North Carolina
                Wake Forest School Of Medicine
              Mar 3, 2022

              STEMI Trial (PPCI in heavy thrombus burden STEMI patients)

              Not yet recruiting
              • STEMI
              • PPCI in heavy thrombus burden STEMI patients
              • (no location specified)
              Mar 30, 2023